Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
A Phase 2b, Multicenter, Randomized, Double-blinded, Placebo-controlled, Parallel-group, Dose-finding Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
The purpose of this study is to evaluate the efficacy and safety of different dose regimens of IMG-007, compared to placebo.
Atopic DermatitisAtopic Dermatitis EczemaEczema
Inmagene LLCNCT07037901
Phase 2
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Moderate to Severe Atopic Dermatitis (SIERRA1)
The main purpose of this study is to see how well different doses of soquelitinib work in participants with atopic dermatitis (AD) as compared to a placebo (pi…
Atopic DermatitisAtopic Dermatitis EczemaEczema+1 more
Corvus Pharmaceuticals, Inc.NCT07441395